INTERSTELLAR LAB

About:

Interstellar Lab designs, manufactures and operates biofarming platform to unleash the power of plants. On Earth and in Space.

Website: https://interstellarlab.com/

Twitter/X: InterstellarLA

Top Investors: Bpifrance, Kima Ventures, Type One Ventures, Starburst Accelerator, 7percent Ventures

Description:

Interstellar Lab is a biotech company founded in 2018 that develops, manufactures and operates advanced bio-farming platforms to help its customer produce the cleanest plant-based ingredients. Its bio-farming technology combines automated farms (Biopods), AI and bioscience with a unique data-driven approach. Its considerably accelerates plant growth while optimizing plant molecular composition. Interstellar Lab provides sustainable plant-based ingredient solutions to large health, beauty and F&B companies. Its bio-farming technology has also convinced NASA and ESA, which contracted with the company to adapt the system for space deployment. The company counts 45 engineers, scientists and researchers located between its flagship 65,000SF BioPod Facility and Plant Lab in Ivry-sur-Seine (France), its SpaceLab at NASA KSC Florida (USA) and its Business Hub in San Francisco (USA).

Total Funding Amount:

$8.95M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Dover, Delaware, United States

Founded Date:

2018-09-05

Contact Email:

contact(AT)interstellarlab.earth

Founders:

Barbara Belvisi

Number of Employees:

11-50

Last Funding Date:

2024-08-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai